$MPAD
MICROPAC INDUSTRIES INC Stock $mpad

$mpad Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121465924012133 Filed on July 09, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$12.63M	$8.063M	$7.443M
YoY Change	95.62%	8.33%	3.55%
Cost Of Revenue	$5.542M	$4.972M	$4.583M
YoY Change	21.11%	8.49%	7.96%
Gross Profit	$7.091M	$3.091M	$2.860M
YoY Change	276.78%	8.08%	-2.82%
Gross Profit Margin	56.13%	38.34%	38.43%
Selling, General & Admin	$2.792M	$2.219M	$2.010M
YoY Change	38.42%	10.4%	8.65%
% of Gross Profit	39.37%	71.79%	70.28%
Research & Development	$716.0K	$549.0K	$625.0K
YoY Change	57.71%	-12.16%	24.5%
% of Gross Profit	10.1%	17.76%	21.85%
Depreciation & Amortization		$266.0K	$273.0K
YoY Change		-2.56%	175.76%
% of Gross Profit		8.61%	9.55%
Operating Expenses	$3.508M	$2.768M	$2.635M
YoY Change	41.97%	5.05%	12.03%
Operating Profit	$3.583M	$323.0K	$225.0K
YoY Change	-708.32%	43.56%	-61.93%
Interest Expense		$10.00K	$3.000K
YoY Change		233.33%
% of Operating Profit		3.1%	1.33%
Other Income/Expense, Net		$706.0K	$33.00K
YoY Change		2039.39%	3200.0%
Pretax Income	$3.668M	$1.019M	$258.0K
YoY Change	-773.03%	294.96%	-56.42%
Income Tax	$697.0K	$173.0K	$44.00K
% Of Pretax Income	19.0%	16.98%	17.05%
Net Earnings	$2.971M	$846.0K	$214.0K
YoY Change	-660.57%	295.33%	-56.42%
Net Earnings / Revenue	23.52%	10.49%	2.88%
Basic Earnings Per Share	$1.15	$0.33	$0.08
Diluted Earnings Per Share	$1.12	$0.32	$0.08
COMMON SHARES
Basic Shares Outstanding	2.578M shares	2.578M shares	2.578M shares
Diluted Shares Outstanding	2.652M shares	2.610M shares	2.614M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$11.02M	$11.66M
YoY Change		-5.52%	-27.21%
Cash & Equivalents	$11.22M	$11.02M	$11.66M
Short-Term Investments
Other Short-Term Assets		$366.0K	$367.0K
YoY Change		-0.27%	-12.83%
Inventory	$12.24M	$13.21M	$11.95M
Prepaid Expenses
Receivables		$5.182M	$4.120M
Other Receivables		$121.0K	$920.0K
Total Short-Term Assets	$34.18M	$29.90M	$29.01M
YoY Change	18.27%	3.04%	-1.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.67M	$23.64M	$24.48M
YoY Change	-2.77%	-3.42%	27.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$475.0K	$86.00K
YoY Change		452.33%
Total Long-Term Assets	$24.14M	$24.12M	$24.56M
YoY Change	-1.23%	-1.82%	28.05%
TOTAL ASSETS
Total Short-Term Assets	$34.18M	$29.90M	$29.01M
Total Long-Term Assets	$24.14M	$24.12M	$24.56M
Total Assets	$58.32M	$54.01M	$53.58M
YoY Change	9.33%	0.81%	9.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.101M	$696.0K	$838.0K
YoY Change	-10.12%	-16.95%	-47.72%
Accrued Expenses		$1.336M	$1.221M
YoY Change		9.42%	-4.61%
Deferred Revenue
YoY Change
Short-Term Debt	$443.0K	$439.0K	$0.00
YoY Change	3.26%
Long-Term Debt Due		$439.0K	$282.0K
YoY Change		55.67%
Total Short-Term Liabilities	$4.081M	$2.796M	$3.110M
YoY Change	10.39%	-10.1%	-25.1%
LONG-TERM LIABILITIES
Long-Term Debt	$15.00M	$15.11M	$15.73M
YoY Change	-2.69%	-3.98%	35.47%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$15.00M	$15.11M	$15.73M
YoY Change	-2.69%	-3.98%	35.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.081M	$2.796M	$3.110M
Total Long-Term Liabilities	$15.00M	$15.11M	$15.73M
Total Liabilities	$19.08M	$17.90M	$18.84M
YoY Change	-0.16%	-4.99%	19.4%
SHAREHOLDERS EQUITY
Retained Earnings	$38.96M	$35.99M	$34.75M
YoY Change	13.85%	3.57%
Common Stock	$308.0K	$308.0K	$308.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.250M	$1.250M	$1.250M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$39.24M	$36.11M	$34.74M
YoY Change
Total Liabilities & Shareholders Equity	$58.32M	$54.01M	$53.58M
YoY Change	9.33%	0.81%	9.91%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	$2.971M	$846.0K	$214.0K
YoY Change	-660.57%	295.33%	-56.42%
Depreciation, Depletion And Amortization		$266.0K	$273.0K
YoY Change		-2.56%	175.76%
Cash From Operating Activities		$583.0K	-$837.0K
YoY Change		-169.65%	-286.0%
INVESTING ACTIVITIES
Capital Expenditures		$33.00K	$1.901M
YoY Change		-98.26%	-153.34%
Acquisitions
YoY Change
Other Investing Activities		$706.0K
YoY Change
Cash From Investing Activities		$673.0K	-$1.901M
YoY Change		-135.4%	-46.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-108.0K	1.155M
YoY Change		-109.35%	-64.24%
NET CHANGE
Cash From Operating Activities		583.0K	-837.0K
Cash From Investing Activities		673.0K	-1.901M
Cash From Financing Activities		-108.0K	1.155M
Net Change In Cash		1.148M	-1.583M
YoY Change		-172.52%	-1464.66%
FREE CASH FLOW
Cash From Operating Activities		$583.0K	-$837.0K
Capital Expenditures		$33.00K	$1.901M
Free Cash Flow		$550.0K	-$2.738M
YoY Change		-120.09%	-168.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	us-gaap	Payments To Acquire Held For Sale Real Estate PaymentsToAcquireHeldForSaleRealEstate		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
	MPAD	Accrued Additions Property Plant Equipment AccruedAdditionsPropertyPlantEquipment		usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	10000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	3000	usd
	us-gaap	Interest Expense InterestExpense	10000	usd
	us-gaap	Interest Expense InterestExpense	-136000	usd
CY2024Q2	us-gaap	Other Income OtherIncome	706000	usd
CY2023Q2	us-gaap	Other Income OtherIncome	36000	usd
	us-gaap	Other Income OtherIncome	711000	usd
	us-gaap	Other Income OtherIncome	37000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1019000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	258000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1232000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	190000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	173000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	209000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	846000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	214000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1023000	usd
	us-gaap	Net Income Loss NetIncomeLoss	158000	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2609509	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2613965	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2609509	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2613965	shares
	us-gaap	Net Income Loss NetIncomeLoss	1023000	usd
	us-gaap	Net Income Loss NetIncomeLoss	158000	usd
	us-gaap	Depreciation Depreciation	531000	usd
	us-gaap	Depreciation Depreciation	376000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	78000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	39000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	14000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	33000	usd
	us-gaap	Payments To Acquire Held For Sale Real Estate PaymentsToAcquireHeldForSaleRealEstate	706000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3437000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	273000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1730000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-120000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-310000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-463000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-796000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-346000	usd
	MPAD	Accrued Compensation AccruedCompensation	-33000	usd
	MPAD	Accrued Compensation AccruedCompensation	215000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-427000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-111000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-14000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-427000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-234000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-7000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-5000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	554000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2297000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	73000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2381000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	706000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	633000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2381000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	258000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	258000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1222000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	211000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-469000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	964000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	718000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3714000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10299000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15375000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11017000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	637000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	143000	usd
	MPAD	Accrued Additions Property Plant Equipment AccruedAdditionsPropertyPlantEquipment	10000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34796000	usd
CY2023Q1	us-gaap	Dividends Dividends	258000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-56000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	34482000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	39000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	214000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	34735000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	35268000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	39000	usd
CY2024Q1	us-gaap	Dividends Dividends	258000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	177000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	35226000	usd
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	39000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	846000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	36111000	usd
CY2024Q2	us-gaap	Revenues Revenues	8063000	usd
CY2023Q2	us-gaap	Revenues Revenues	7443000	usd
	us-gaap	Revenues Revenues	14181000	usd
	us-gaap	Revenues Revenues	13632000	usd
CY2024Q2	us-gaap	Revenues Revenues	8063000	usd
CY2023Q2	us-gaap	Revenues Revenues	7443000	usd
	us-gaap	Revenues Revenues	14181000	usd
	us-gaap	Revenues Revenues	13632000	usd
CY2024Q2	MPAD	Domestic Direct DomesticDirect	5009000	usd
CY2024Q2	MPAD	Domestic Distrbution DomesticDistrbution	2502000	usd
CY2024Q2	MPAD	International Distribution InternationalDistribution	552000	usd
CY2023Q2	MPAD	Domestic Direct DomesticDirect	5268000	usd
CY2023Q2	MPAD	Domestic Distrbution DomesticDistrbution	1654000	usd
CY2023Q2	MPAD	International Distribution InternationalDistribution	521000	usd
CY2023Q2	us-gaap	Revenues Revenues	7443000	usd
	MPAD	Domestic Direct DomesticDirect	9014000	usd
	MPAD	Domestic Distrbution DomesticDistrbution	4251000	usd
	MPAD	International Distribution InternationalDistribution	916000	usd
	us-gaap	Revenues Revenues	14181000	usd
	MPAD	Domestic Direct DomesticDirect	8737000	usd
	MPAD	Domestic Distrbution DomesticDistrbution	4098000	usd
	MPAD	International Distribution InternationalDistribution	797000	usd
	us-gaap	Revenues Revenues	13632000	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	4602000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8021000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3644000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	580000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	307000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	408000	usd
CY2024Q2	us-gaap	Deferred Revenue DeferredRevenue	308000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	618000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1192000	usd
	MPAD	Deferred Revenue Recognized DeferredRevenueRecognized	398331000	usd
CY2020Q1	us-gaap	Lessee Finance Lease Remaining Lease Term LesseeFinanceLeaseRemainingLeaseTerm	P3Y
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	165000	usd
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	165000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	14000	usd
CY2020Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0325	pure
CY2024Q2	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2024Q2	MPAD	Gain On Sale Of Manufacturing Facility GainOnSaleOfManufacturingFacility	706000	usd
CY2024Q2	MPAD	Sale Of Manufacturing Facility SaleOfManufacturingFacility	444000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zyNzjl6Q9wZ4" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_869_zHLaV78ZTsL3">Use of Estimates</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q2	MPAD	Fair Value Financial Assets Liabilities Recurring Basis FairValueFinancialAssetsLiabilitiesRecurringBasis	0	usd
CY2023Q4	MPAD	Fair Value Financial Assets Liabilities Recurring Basis FairValueFinancialAssetsLiabilitiesRecurringBasis	0	usd
CY2024Q2	MPAD	Fair Value Non Financial Assets Non Recurring Basis FairValueNonFinancialAssetsNonRecurringBasis	0	usd
CY2023Q4	MPAD	Fair Value Non Financial Assets Non Recurring Basis FairValueNonFinancialAssetsNonRecurringBasis	0	usd
CY2023Q2	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	0	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-04-23
CY2024Q2	us-gaap	Notes Payable NotesPayable	15673000	usd
CY2024Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	128000	usd
CY2024Q2	MPAD	Net Debt NetDebt	15545000	usd
CY2024Q2	us-gaap	Debt Current DebtCurrent	439000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15106000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	218000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	463000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	463000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	479000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	495000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	13555000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	15673000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2024Q2	MPAD	Restricted Stock Units RestrictedStockUnits	31194	shares
CY2023Q2	MPAD	Restricted Stock Units RestrictedStockUnits	35650	shares
	MPAD	Restricted Stock Units RestrictedStockUnits	31194	shares
	MPAD	Restricted Stock Units RestrictedStockUnits	35650	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2609509	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2613965	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2609509	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2613965	shares
	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2023-12-05
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2024-01-10
	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2024-02-09
	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2022-12-07
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-01-11
	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-02-10
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	39000.00	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	39000.0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	78000.00	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	39000.0	usd
CY2024Q2	MPAD	Stockbased Unvested Compensation Expense For Second Year StockbasedUnvestedCompensationExpenseForSecondYear	156000	usd
CY2024Q2	MPAD	Stockbased Unvested Compensation Expense For Third Year StockbasedUnvestedCompensationExpenseForThirdYear	156000	usd
CY2024Q2	MPAD	Stockbased Unvested Compensation Expense StockbasedUnvestedCompensationExpense	312000	usd

Files In Submission

Name	View Source	Status
0001214659-24-012133-index-headers.html	Edgar Link	pending
0001214659-24-012133-index.html	Edgar Link	pending
0001214659-24-012133.txt	Edgar Link	pending
0001214659-24-012133-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mpad-20240525.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
mpad-20240525_def.xml	Edgar Link	unprocessable
mpad-20240525_cal.xml	Edgar Link	unprocessable
mpad-20240525_lab.xml	Edgar Link	unprocessable
mpad-20240525_pre.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
x7824210q.htm	Edgar Link	pending
x7824210q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MPAD
MICROPAC INDUSTRIES INC Stock $mpad

2024 Q3 Form 10-Q Financial Statement

#000121465924012133 Filed on July 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPAD MICROPAC INDUSTRIES INC Stock $mpad

2024 Q3 Form 10-Q Financial Statement

#000121465924012133 Filed on July 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPAD
MICROPAC INDUSTRIES INC Stock $mpad